Helicobacter Pylori Eradication
2
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
2
Early DiscoveryClinical DevelopmentMarket
Drug Modality Breakdown
Small Molecule
1100%
+ 1 programs with unclassified modality
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Grand MedicalIsrael - Ramat Gan
1 program1
Bifidobacterium tetrad live bacteria tablet plus Helicobacter pylori quadruple eradication therapyPhase 41 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Grand MedicalBifidobacterium tetrad live bacteria tablet plus Helicobacter pylori quadruple eradication therapy
Livzon PharmaceuticalIlaprazole
Clinical Trials (2)
Total enrollment: 238 patients across 2 trials
NCT04034641Grand MedicalBifidobacterium tetrad live bacteria tablet plus Helicobacter pylori quadruple eradication therapy
Effect of Probiotics on Helicobacter Pylori Eradication
Start: Jun 2019Est. completion: Dec 2021238 patients
Phase 4Unknown
Efficacy and Safety of 1-week Triple Therapy With Ilaprazole for the Eradication of Helicobacter Pylori
Start: Sep 2014Est. completion: Jun 2015
Phase 4Completed
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.